focus -WSS

focus

author：leisure time 2025-09-03 09:27:44 - browse：1

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Merck to acquire Harpoon Therapeutics for $680 million

Wikipedia

hotspot

WSS

Life science postdocs should get big pay hike, NIH panel says

Merck to acquire Harpoon Therapeutics for $680 million

Physician assistants need a new name. Here's what it should be

American taxpayers paid $1.8 trillion in health care costs in 2022

STAT Virtual Event: JPM Recap, Live!

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

hotspot

focus

entertainment

In Memoriam: Notable people who died in 2023

Ascension's ugly legal battle over care for poor patients in Texas

Bright Health sells Medicare Advantage business to Molina

Study on Amgen’s bispecific immunotherapy produces positive data

The high cost of giving birth even with insurance

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

What does generative AI mean for health care? We asked experts

Medicare Advantage coverage denials need scrutiny, senators say

The high cost of giving birth even with insurance

STAT Readout Newsletter: Biotech news today

entertainment

Allen Institute goes after foundational questions, CEO Costa says

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

JPM pitch from hospitals? Revenue streams outside of patient care

Fauci's latest grilling in Congress: 9 hours, behind closed doors

J&J lung cancer data amount to new salvo against AstraZeneca

Wikipedia

hotspot

hotspot

hotspot